Kratom laws in Iowa
We didn't find any Iowa law restricting the sale or shipping of kratom and 7-OH products. Federal law still applies.
What we searched
- https://www.legis.iowa.gov/docs/code/2026/124.pdf (Iowa Code 2026 ch. 124, no mitragynine)
- https://www.legis.iowa.gov/publications/search?q=kratom
- https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=HF%202133&ga=91
- https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=SF%202192&ga=91
- https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=HF%20612&ga=91
2026 HF 2133 (kratom to Schedule I) passed House 3/17/2026 but stalled in Senate; HF 612 (2025 regulation) died in subcommittee. Board of Pharmacy rules not checked.
Federal
These apply in every state.
BannedMitragynine pseudoindoxyl ("MP", "pseudo") and the 7-OH derivatives MGM-15/MGM-16 are temporarily Schedule I nationwide; don't sell or ship products containing them anywhere in the US.
Exact text
(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672 3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'- indolizine]-7'-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ... (90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673 ... 15; also known as dihydro-7-hydroxymitragynine) including its ... (91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674 ... (commonly known as MGM-16; also known as 9-fluoro-dihydro-7- hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine
BannedConcentrated 7-OH products (more than 1 mg 7-OH per gram/mL, or 7-OH more than 1% of the mitragynine content) are about to become federal Schedule I nationwide (DEA order expected on or after Nov. 13, 2026), and FDA already says 7-OH can't lawfully be sold as a supplement or food; don't sell 7-OH tablets or shots.
Exact text
The substances [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] be controlled in schedule I [pursuant to 21 U.S.C. 811(h)] when either substance alone, or their combined amount if both present, is: (A) Above a specified threshold concentration, that is, greater than 1 mg per gram (for solid powders, encapsulated material, or other solid forms) or greater than 1 mg per milliliter (for liquid preparations), OR (B) The mass of mitragynine present divided by the mass of [7- hydroxymitragynine], or [mitragynine pseudoindoxyl], or the combined amount of [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] if both present, is less than 100. ... The temporary scheduling order will be published in the Federal Register on or after November 13, 2026.